Skip to main content

ivabradine (Procoralan®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal TA267: Ivabradine for treating chronic heart failure

Medicine details

Medicine name ivabradine (Procoralan®)
Formulation film-coated tablet
Reference number 889
Indication

Treatment of chronic heart failure NYHA II to IV class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated

Company Servier Laboratories Ltd
BNF chapter Cardiovascular system
Assessment type N/A
Status Excluded due to NICE appraisal
Date of issue 27/01/2012
NICE guidance

TA267: Ivabradine for treating chronic heart failure

Follow AWTTC: